Literature DB >> 21689649

Graft survival and endothelial outcomes in the new era of endothelial keratoplasty.

Sanjay V Patel1.   

Abstract

Corneal endothelial cells do not proliferative in vivo sufficiently to enable endothelial regeneration, and thus diseases of the corneal endothelium, which cause poor vision and discomfort, require treatment by transplantation of cadaveric donor corneal endothelial cells. The two major goals of any corneal transplant procedure are to restore vision and to promote longevity of the donor cornea by maintaining a healthy donor endothelial cell density. Over the last decade, the surgical treatment for endothelial disease has rapidly evolved toward endothelial keratoplasty, or selective tissue transplantation, and away from full-thickness penetrating keratoplasty (PK). While endothelial keratoplasty offers distinct advantages over PK in terms of visual outcomes and a smaller incision, the new surgical manipulations of the fragile donor tissue cause significant donor endothelial cell trauma. As a result, donor endothelial cell loss is much higher during the first month after Descemet stripping endothelial keratoplasty (DSEK) compared to after PK, and the primary (or more appropriately, iatrogenic) graft failure rate of 5% remains unacceptably high. Nevertheless, the rate of endothelial cell loss rapidly decreases beyond 6 months after DSEK, and thus endothelial cell loss at 5 years after DSEK appears to be lower than that at 5 years after PK. In the absence of primary (iatrogenic) graft failure, graft survival through 5 years after DSEK is similar to that after PK. Given the promising longer-term endothelial outcomes of DSEK, the quest for optimizing the visual outcomes has spurred interest in Descemet membrane endothelial keratoplasty (DMEK). While early results after DMEK suggest better visual outcomes than after DSEK, the technique needs to be simplified, and longer-term outcomes must show an advantage over DSEK with respect to vision, endothelial cell loss, and graft survival. DMEK also has a high rate of primary (iatrogenic) graft failure, and additional donor tissue wastage occurs when preparation of DMEK grafts is unsuccessful. This review discusses endothelial keratoplasty techniques and the associated endothelial outcomes.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21689649      PMCID: PMC3902807          DOI: 10.1016/j.exer.2011.05.013

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  106 in total

1.  Endothelial keratoplasty: the influence of preoperative donor endothelial cell densities on dislocation, primary graft failure, and 1-year cell counts.

Authors:  Mark A Terry; Neda Shamie; Edwin S Chen; Karen L Hoar; Paul M Phillips; Daniel J Friend
Journal:  Cornea       Date:  2008-12       Impact factor: 2.651

2.  Endothelial keratoplasty: the influence of insertion techniques and incision size on donor endothelial survival.

Authors:  Mark A Terry; Hisham A Saad; Neda Shamie; Edwin S Chen; Paul M Phillips; Daniel J Friend; Jeffrey D Holiman; Christopher Stoeger
Journal:  Cornea       Date:  2009-01       Impact factor: 2.651

3.  The effect of corneal light scatter on vision after descemet stripping with endothelial keratoplasty.

Authors:  Sanjay V Patel; Keith H Baratz; David O Hodge; Leo J Maguire; Jay W McLaren
Journal:  Arch Ophthalmol       Date:  2009-02

4.  Simple technique for graft insertion in Descemet-stripping (automated) endothelial keratoplasty using a 30-gauge needle.

Authors:  Chandra Balachandran; Lisanne Ham; Rénuka S Birbal; Tse-Hang Wong; Jacqueline van der Wees; Gerrit R J Melles
Journal:  J Cataract Refract Surg       Date:  2009-04       Impact factor: 3.351

5.  A modified technique for descemet membrane stripping automated endothelial keratoplasty to minimize endothelial cell loss.

Authors:  Massimo Busin; Priya R Bhatt; Vincenzo Scorcia
Journal:  Arch Ophthalmol       Date:  2008-08

6.  Descemet-stripping automated endothelial keratoplasty: six-month results in a prospective study of 100 eyes.

Authors:  Edwin S Chen; Mark A Terry; Neda Shamie; Karen L Hoar; Daniel J Friend
Journal:  Cornea       Date:  2008-06       Impact factor: 2.651

7.  Risk factors for human corneal graft failure within the Australian corneal graft registry.

Authors:  Keryn A Williams; Marie Lowe; Christine Bartlett; Thu-Lan Kelly; Douglas J Coster
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

8.  Histologic analysis of descemet stripping in posterior lamellar keratoplasty.

Authors:  Ludwig M Heindl; Carmen Hofmann-Rummelt; Ursula Schlötzer-Schrehardt; Friedrich E Kruse; Claus Cursiefen
Journal:  Arch Ophthalmol       Date:  2008-04

9.  Randomized, prospective comparison of precut vs surgeon-dissected grafts for descemet stripping automated endothelial keratoplasty.

Authors:  Marianne O Price; Kashif M Baig; Jacob W Brubaker; Francis W Price
Journal:  Am J Ophthalmol       Date:  2008-04-24       Impact factor: 5.258

10.  Endothelial cell loss after descemet stripping with endothelial keratoplasty influencing factors and 2-year trend.

Authors:  Marianne O Price; Francis W Price
Journal:  Ophthalmology       Date:  2007-09-14       Impact factor: 12.079

View more
  33 in total

1.  Endothelial keratoplasty: is Descemet membrane endothelial keratoplasty the Holy Grail of lamellar surgery? No.

Authors:  M Tsatsos; V S Liarakos; C MacGregor; I Athanasiadis; E T Detorakis; M M Moschos; P Hossain; D F Anderson
Journal:  Eye (Lond)       Date:  2017-04-21       Impact factor: 3.775

2.  Incidental central tear in Descemet membrane endothelial complex during Descemet membrane endothelial keratoplasty.

Authors:  Vikas Mittal; Ruchi Mittal; Rajat Jain; Virender S Sangwan
Journal:  BMJ Case Rep       Date:  2014-06-27

3.  Objective assessment of the corneal endothelium in Fuchs' endothelial dystrophy.

Authors:  Jay W McLaren; Lori A Bachman; Katrina M Kane; Sanjay V Patel
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-26       Impact factor: 4.799

Review 4.  Descemet stripping endothelial keratoplasty--rapid recovery of visual acuity.

Authors:  Philip Maier; Thomas Reinhard; Claus Cursiefen
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

5.  A mathematical model to predict endothelial cell density following penetrating keratoplasty with selective dropout from graft failure.

Authors:  Tonya D Riddlesworth; Craig Kollman; Jonathan H Lass; Sanjay V Patel; R Doyle Stulting; Beth Ann Benetz; Robin L Gal; Roy W Beck
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-25       Impact factor: 4.799

6.  Murine corneal transplantation: a model to study the most common form of solid organ transplantation.

Authors:  Xiao-Tang Yin; Deena A Tajfirouz; Patrick M Stuart
Journal:  J Vis Exp       Date:  2014-11-17       Impact factor: 1.355

7.  Modified thin manual Descemet stripping endothelial keratoplasty with air-guided, non-pachymetric donor lenticule dissection: outcomes of graft thickness and complication rate.

Authors:  Abdo Karim Tourkmani; Andrew M J Turnbull; Parwez N Hossain; Aristides Konstantopoulos; David F Anderson
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

8.  Inflammatory cytokine TNF-α promotes corneal endothelium apoptosis via upregulating TIPE2 transcription during corneal graft rejection.

Authors:  Qun Wang; Chao Wei; Li Ma; Xin Wang; Lin Li; Qingjun Zhou; Weiyun Shi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-26       Impact factor: 3.117

9.  Fuchs' endothelial corneal dystrophy: subjective grading versus objective grading based on the central-to-peripheral thickness ratio.

Authors:  Daniel J Repp; David O Hodge; Keith H Baratz; Jay W McLaren; Sanjay V Patel
Journal:  Ophthalmology       Date:  2013-01-28       Impact factor: 12.079

10.  Visual outcome and histological findings following femtosecond laser-assisted versus microkeratome-assisted DSAEK.

Authors:  S Heinzelmann; P Maier; D Böhringer; C Auw-Hädrich; T Reinhard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-10       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.